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Abstract (400 words max):  
Several epidemiological, clinical and preclinical studies reported gender differences in lung 
cancer risk. These observations suggest that estrogens might be implicated in the etiology of 
lung cancer development in women. However, the role of estrogens and their receptors 
remains unclear and available data are conflicting.  
 
Aim: Our aim is to understand gender differences observed in lung cancer progression. In this 
study, we compared lung cancer development in male and female immunocompetent mice in 
two different experimental models : 1) chemically-induced lung cancer, 2) orthotopic 
instillation of lewis lung carcinoma cells (LLC) into the lung parenchyma. 
 
Results: We did not observe any differences between male and female regarding lung 
carcinogenesis (model 1). However, in the orthotopic instillation model (model 2), lung cancer 
development was increased in female mice. In addition, ovariectomized female mice 
displayed decreased lung cancer development and exogenous E2 supplementation rescued 
lung cancer growth in ovariectomized mice. In order to further characterize the molecular 
mechanisms induced by E2 to increase lung cancer development, we treated mice with 
estrogen receptor (ER) antagonists targeting ERα or ERβ. In female mice treated with 
tamoxifen (ER antagonist used in clinic to treat breast cancer) or with MPP (ERα antagonist), 
lung tumor growth was significantly decreased. ERβ antagonist (PHTPP) did not display any 
significant effects. In male mice, the various ER antagonists tested did not modulate lung 
cancer development. These results suggest that ERα is the receptor mediating the pro-tumor 
effect of E2 observed in female mice. Finally, we showed that E2 does not increase LLC 
proliferation suggesting that a modulation of the tumor microenvironment is responsible for 
the increased cancer development 
 
Conclusion: E2 promotes lung cancer growth in female through a modulation of tumor 
microenvironment via the activation of ERα. These new insights may lead to an optimization 
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